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Abstract
Background: To assess the safety of abandoning the next day post-operative review in preference for
assessment only 2 hours post-surgery for both phacoemulsification and extracapsular surgery with heavier
molecular weight ocular viscoelastic devices (OVD).
Methods: 475 patients who underwent uncomplicated cataract surgery using heavier molecular weight
ocular viscoelastic device (Healon GV) were studied. Of these 415 were phacoemulsification and 60
extracapsular and none received Intraocular pressure (IOP) lowering prophylaxis at the end of surgery. All
were examined at 2 hours post-surgery and on the following day. Results were tabulated and analysed
assessing wound stability, corneal clarity, anterior chamber reaction and IOP.
Results: In the time between the two assessments 44 (10.6%) patients developed a total of 53 new
problems, with a majority being increases in IOP. Based on the lower threshold of IOP of 30 mmHg, the
incidence of new problems at the next-day assessment was 9.8% (95% CI: 7.0 to 13.6) in the
phacoemulsification group and 16.3% (7.3 to 29.7)in the extracapsular surgery group. At the higher
threshold of IOP of 35 mmHg the corresponding figures were 6.6% and 16.3%.
Conclusion: There is a higher incidence of new problems at the next-day assessment than previous studies
with conventional OVD. Therefore results from previous studies using standard OVDs cannot be simply
extrapolated to heavier molecular weight OVDs. When these agents are used, routine use of an ocular
hypotensive agent may be necessary to increase the safety of abandoning the review on the first post-
operative day for phacoemulsification patients. This is to be studied.
Background
The rising and, in some cases, universal trend towards day
case cataract surgery raises a vexed question about the tim-
ing of postoperative review. This is particularly true if the
aim is to do a "true" day case surgery where the patient is
not seen in the hospital the next morning and so goes
home on the day of surgery. A number of centres do send
patients home on the day of surgery but they are reviewed
on the next day either in the hospital or by a home visit by
a trained staff member. Previous studies[1-5] have sug-
gested that it is safe for patients to be seen in the immedi-
ate few hours after surgery and then to be seen a week
later, particularly for uncomplicated phacoemulsification.
None of these studies, however, have commented on
whether the safety of omitting the review on the first post-
operative day surgery persists if a heavier molecular
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surgery. In this study we assess the safety of abandoning
the next day post-operative review in preference for assess-
ment only at 2 hours post-surgery for both phacoemulsi-
fication and extracapsular surgery with heavier molecular
weight OVD.
Methods
475 consecutive patients who underwent uncomplicated
cataract surgery at our hospital were studied. In all cases,
irrespective of the type of cataract extraction, Healon GV
was used. Healon GV has a molecular mass of 5 million,
with a viscosity at rest of 2.5 million mPas and a elasticity
which 10 times higher than the Healon OVD. It is also a
very cohesive OVD. The majority 415(87 %) underwent
phacoemulsification, while the rest 60(13%) had ext-
racapsular cataract extraction. The phacoemulsification
procedure was with a scleral tunnel incision and was a
standard procedure using the divide and conquer tech-
nique. Meticulous attempts were made to remove as much
as possible of the OVD either by automated or manual
irrigation-aspiration, using the rock-and-roll technique.
Intra-aqueal miochol was routinely used after this. No
topical or systemic agent was used prophylactically post-
operatively.
None of the patients had any form of Intraocular Pressure
(IOP) prophylaxis at the end of surgery. The grade of sur-
geon varied from Consultant to Senior House Officer,
with almost all operated upon by the Consultant.
The patients were examined 2 hours following surgery
and on the next day. The 2 hours time interval following
surgery was chosen firstly to compare with previous stud-
ies[1] and secondly to assist with easing patient discharge
on the day of surgery, particularly when they had late
afternoon surgery. Parameters assessed included corneal
clarity, incision stability and anterior chamber inflamma-
tion and these were given a grading on each occasion. IOP
was measured in the usual manner using a Goldmann
Applanation tonometer. Two cut-off levels of 30 mmHg
and 35 mmHg were chosen for analysis of IOP based on
previous guidelines/studies[1,5,6] and common practice.
Some guidelines and studies[1,6]have indicated that as
long as the rise in IOP is only for a short length of time (as
is the case after uncomplicated cataract surgery), IOP up
to 35 mm Hg does not require active intervention. On the
other hand[5], it has been conventional practice to treat
IOP of 30 mmHg and above in order to prevent retinal
vein occlusions and damage to the optic nerve head[7].
Treatment for adverse events was given as soon as they
were first noted. Those that had an IOP above 30 mm Hg
were treated to lower the IOP using Acetazolamide or a
topical B blocker.
The prevalence of adverse events at the 2 hour and at the
next-day assessments was computed and new events
occurring between the two assessments identified, and
their incidence estimated. Ninety-five percent confidence
intervals were computed for incidence rates using the
exact binomial method. The significance of differences in
rates between phacoemulsification and extracapsular sur-
gery groups was tested using Fisher's exact test.
Results
Full data on adverse events at both assessments was avail-
able on 423 (89%) patients. The prevalence of adverse
events at the two assessments is presented in Table 1.
Anterior chamber reactions were significantly more com-
mon following extracapsular surgery at both assessments
(p ≤ 0.001). There were no significant differences (at 2
hours p = 0.45; next day p = 0.35) in problems with cor-
neal clarity or IOP between the surgical groups. Incision
instability was rare, but significantly more common after
extracapsular surgery at the next-day assessment.
In the time between the two-hour and next-day assess-
ments 44 (10.6%) patients developed a total of 53 new
problems (Table 2). The majority of these problems were
increases in IOP (29 showed increases ≥ 30 mmHg and 16
≥ 35 mmHg) but there were also 13 patients with
increased anterior chamber activity, 9 instances of corneal
oedema/haze and 2 patients with incision instability.
Both cases of incision instability had received phacoemul-
sification, but otherwise there was no significant differ-
ence in the incidence of new problems with type of
surgery.
Based on the lower threshold of IOP of 30 mmHg, the
incidence of new problems at the first post-operative day
was 9.8% in the phacoemulsification group and 16.3% in
the extracapsular surgery group. At the higher threshold of
IOP of 35 mmHg the corresponding figures were 6.6%
and 16.3%.
Discussion and conclusion
Heavier molecular weight OVDs have the advantage of
maintaining the anterior chamber and affording better
protection to the corneal endothelium than standard
molecular weight OVDs. The latter property is particularly
useful when the patient has a pre-existing corneal dystro-
phy involving the endothelium or any degree of endothe-
lial decompensation. Though the use of these higher
molecular weight OVDs is not widespread for routine cat-
aract surgery, they nevertheless are used by a proportion
of surgeons. If any OVD does remain at the end of surgery,
this can contribute to increase resistance to aqueous
drainage following surgery with a consequent rise of IOP.
It is a known that these can remain in the eye to some
degree despite meticulous attempts made to aspirate themPage 2 of 4
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Table 2: Incidence of new problems
Incidence of new problems New cases Incidence rate 95% confidence interval
Phacoemulsification
Any problems (IOP >=30 mmHg) 36 9.8% (7.0% to 13.6%)
Any problems (IOP >=35 mmHg) 25 6.6% (4.5% to 9.9%)
Extracapsular
Any problems (IOP >=30 mmHg) 8 16.3% (7.3% to 29.7%)
Any problems (IOP >=35 mmHg) 8 16.3% (7.3% to 29.7%)
Combined
Any problems (IOP >=30 mmHg) 44 10.6% (7.8% to 14.0%)
Any problems (IOP >=35 mmHg) 33 8.0% (5.5% to 11.0%)
Table 1: Prevalence of adverse events
Phacoemulsification Extracapsular Total P-value
(n = 415)* (n = 60)† (n = 475) ‡ (Fisher's exact test)
n (%age) n (%age) n (%age)
2 hour follow-up
Corneal clarity 32 8.1% 6 10.9% 38 8.5% P = 0.45
Incision stability 2 0.5% 0 0.0% 2 0.5% P = 1.00
Anterior chamber reaction 25 6.4% 12 22.2% 37 8.3% P = 0.001
IOP ≥ 30 mmHg 27 7.2% 3 6.0% 30 7.1% P = 1.00
IOP ≥ 35 mmHg 15 4.0% 0 0.0% 15 3.5% P = 0.24
Next day follow-up
Corneal clarity 21 5.3% 5 9.1% 26 5.8% P = 0.35
Incision stability 0 0.0% 2 3.6% 2 0.5% P = 0.02
Anterior chamber reaction 28 7.1% 15 27.8% 43 9.6% P < 0.001
IOP ≥ 30 mmHg 33 8.8% 4 8.0% 37 8.7% P = 1.00
IOP ≥ 35 mmHg 15 4.0% 3 6.0% 18 4.3% P = 0.46
New problems first appearing the next day
Corneal clarity 7 1.8% 2 3.6% 9 2.0% P = 0.31
Incision stability 0 0.0% 2 3.6% 2 0.5% P = 0.02
Anterior chamber reaction 9 2.3% 4 7.4% 13 2.9% P = 0.06
IOP ≥ 30 mmHg 26 7.0% 3 6.0% 29 6.9% P = 1.00
IOP ≥ 35 mmHg 13 3.5% 3 6.0% 16 3.8% P = 0.42
Numbers evaluable vary between (*) 373 and 393; (†) 50 and 55; (‡) 423 and 448
BMC Ophthalmology 2007, 7:2 http://www.biomedcentral.com/1471-2415/7/2at the end of surgery. Thus they are the main contributors
to resistance to aqueous drainage following surgery, with
consequent rise of IOP. As discussed in previous papers
retained OVD may cause either trabecular meshwork
blockage or post-operative capsular bag hyper distention,
anteroplacement of the IOL optic and capsular block from
occlusion of the circular opening of the IOL optic[8]. The
raised IOP then has a transient bearing on clarity despite
increased protection to the corneal endothelium intraop-
eratively by the OVD.
As evident from the results the proportion of patients
requiring intervention on the day following surgery was
10.6%. The rate was slightly lower in the larger phacoe-
mulsification group. The majority of those requiring inter-
vention was due to IOP. Nevertheless in a "true" day case
arrangement, the ones that did need intervention would
have been missed if they had not been seen on the day fol-
lowing surgery. The Royal College of Ophthalmologists
guidelines advises, in view of the very low incidence of
endophthalmitis (0.14%), that patients should be pre-
warned about the symptoms and that robust arrange-
ments need to be in place to ensure that patients not
reviewed the next day should have easy access to advise
and assessment should they be symptomatic at any
time[9]. While in our study higher molecular weight OVD
was used for all patients, other studies have shown results
with standard OVDs. A previous study [10] has shown
that with conventional OVD usage in uncomplicated
phacoemulsification the number of patients requiring
intervention/change to their post-operative treatment was
2.2%. Another study[1] has shown that with conventional
OVD, 10% of patients required intervention at 2 hours
post-operatively for raised IOP (cut-off used ≥ 35 mm Hg)
but neither these patients or any new ones required any
intervention on the following day. Thus, we have
observed a higher incidence of new problems at the next-
day assessment than previous studies of conventional
OVDs.
At the present time of increasing day case surgery and the
huge variety of operative settings, it must be borne in
mind that the safety of this type of surgery cannot be taken
for granted particularly when greater viscosity OVDs are
used. Results from studies using standard OVDs cannot be
simply extrapolated. However, given that the majority of
identified problems were from raised IOP, there may be a
role for using IOP prophylaxis at the end of surgery. The
way forward would be to undertake a study wherein
patients undergoing uncomplicated cataract surgery with
heavier molecular weight OVDs would have to be sepa-
rated into 2 groups by randomisation. One group receiv-
ing IOP lowering prophylaxis at the end of surgery, with
the other group as a control and the timing of post-oper-
ative review being the same as in this study.
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